• Home
  • About us
  • Contact us
  • DMCA
Forbes.llc
  • Home
  • Innovation
    • 5G
    • AI
    • Big Data
    • Cloud
    • Cloud 100
    • Consumer Tech
    • COP26
    • Cybersecurity
    • Enterprise Tech
    • Future Of Work
    • Games
  • Leadership
    • Careers
    • CEO Network
    • CFO Network
    • CHRO Network
    • CIO Network
    • CMO Network
    • Money
      • ETFs & Mutual Funds
      • Fintech
      • Hedge Funds & Private Equity
      • Investing
      • Investing Basic
      • Markets
      • Personal Finance
      • Premium Investing Newsletters
  • Forbes Digital Assets
    • Dashboard
    • Traded Assets
    • Research
    • Events
    • Crypto Portfolios
  • Business
    • Aerospace & Defense
    • Energy
    • Food & Drink
    • Hollywood & Entertainment
    • Manufacturing
    • Media
    • Policy
  • Small Business
    • Small Business Strategy
    • Enterprise Tech
    • Franchises
  • Lifestyle
    • Arts
    • Boats & Planes
    • Cars & Bikes
    • Dining
    • Real Estate
      • Commercial Real Estate
      • Residential Real Estate
      • Forbes Global Properties
      • Vetted
No Result
View All Result
  • Home
  • Innovation
    • 5G
    • AI
    • Big Data
    • Cloud
    • Cloud 100
    • Consumer Tech
    • COP26
    • Cybersecurity
    • Enterprise Tech
    • Future Of Work
    • Games
  • Leadership
    • Careers
    • CEO Network
    • CFO Network
    • CHRO Network
    • CIO Network
    • CMO Network
    • Money
      • ETFs & Mutual Funds
      • Fintech
      • Hedge Funds & Private Equity
      • Investing
      • Investing Basic
      • Markets
      • Personal Finance
      • Premium Investing Newsletters
  • Forbes Digital Assets
    • Dashboard
    • Traded Assets
    • Research
    • Events
    • Crypto Portfolios
  • Business
    • Aerospace & Defense
    • Energy
    • Food & Drink
    • Hollywood & Entertainment
    • Manufacturing
    • Media
    • Policy
  • Small Business
    • Small Business Strategy
    • Enterprise Tech
    • Franchises
  • Lifestyle
    • Arts
    • Boats & Planes
    • Cars & Bikes
    • Dining
    • Real Estate
      • Commercial Real Estate
      • Residential Real Estate
      • Forbes Global Properties
      • Vetted
Social icon element need JNews Essential plugin to be activated.
No Result
View All Result
Forbes LLC
No Result
View All Result

Featuring Johnson & Johnson, Pfizer and Novartis

by
February 1, 2023

[ad_1]

Dublin, February 1, 2023 /PRNewswire/ — “Global Pharmaceuticals and Pharmaceutical Manufacturing – Industry Market Research Report” report added of ResearchAndMarkets.com Recruitment.

In the five years to 2019, pharmaceutical companies have benefited from aging populations in developed economies and a growing middle class in emerging economies. This provided a larger customer base for operators in the global pharmaceutical and pharmaceutical manufacturing industry. Many manufacturers also took advantage of local demand for drugs that may differ from developed markets.

In addition, the growing global middle class offers additional growth opportunities given increasing access to medicines and increasing per capita spending on medicines. Many manufacturers are expanding their global presence to leverage local market needs and build relationships with government agencies that can accelerate drug approvals or implement high reimbursement rates.

Nevertheless, the patent cliff continues to hamper industry revenues. As blockbuster drugs lose patent exclusivity, the market is flooded with lower-priced generics. Over the five-year period to 2024, industry revenues are projected to grow as global economic health is expected to continue.

This industry consists of companies that manufacture biological, pharmaceutical and pharmaceutical products in various forms such as ampoules, tablets, capsules, vials, ointments, powders, solutions and suspensions. The overall pharmaceutical market can be divided into prescription-based or ethical products and over-the-counter drugs. Industrial products are mainly distributed through wholesalers and then sold through pharmacies or distributed in hospitals.

This report covers the scope, size, disposal and growth of the industry, including key sensitivities and success factors. It also includes analysis of five-year industry forecasts, growth rates, industry players and their market shares.

Main topics:

About this industry

  • Industry definition
  • main activity
  • similar industry
  • Other resources

Industry overview

Industry performance

  • executive summary
  • Main external driver
  • current performance
  • industry outlook
  • industrial life cycle

Products and markets

  • supply chain
  • Products and services
  • demand determinant
  • major market
  • international trade
  • Office

competitive landscape

  • Concentration of market share
  • Key success factors
  • Cost structure benchmark
  • Competitive basis
  • barrier to entry
  • Industry globalization

major companies

operating conditions

  • capital intensity
  • technology & system
  • Earnings volatility
  • Regulations and policies
  • industrial support

Key stats

  • industry data
  • Annual change
  • Main ratio

Terminology and Glossary

A selection of companies mentioned in this report include:

  • Johnson & Johnson
  • Pfizer
  • Novartis AG

For more information on this report, please visit https://www.researchandmarkets.com/r/mwe4ne.


Media contact:

research and market
Laura WoodSenior Manager
[email protected]

For EST office hours, please call +1-917-300-0470.
US/Canada Toll Free +1-800-526-8630
For GMT office hours, please call +353-1-416-8900.

US Fax: 646-607-1907
Fax (outside US): +353-1-481-1716

SOURCE Research and Market

[ad_2]

Source link

Next Post
Rockford business owner offers $10,000 to catch William Jones

Rockford business owner offers $10,000 to catch William Jones

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Pet Insurance That Covers Pre-Existing Conditions – Forbes Advisor
  • Pet Insurance That Covers Pre-Existing Conditions – Forbes Advisor
  • Pros and Cons – Forbes Advisor
  • Home
  • About us
  • Contact us
  • DMCA

© 2022 forbes - Copyrights reserved by Forbes LLC.

No Result
View All Result
  • Home
  • Review
  • Apple
  • Applications
  • Computers
  • Gaming
  • Gear
    • Audio
    • Camera
    • Smartphone
  • Microsoft
  • Photography
  • Security

© 2022 forbes - Copyrights reserved by Forbes LLC.